Loading...

Sushil Mahata

Title(s)Adjunct Professor, Medicine
SchoolHealth Sciences
Phone858-552-8585
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    ShEEP Request for ACQUITY UPLC H-Class PLUS Bio System
    VA IS1BX005048Sep 1, 2019 - Sep 30, 2020
    Role: Principal Investigator
    Catestatin improves glucose homeostasis and insulin sensitivity in diet-induced obese mice
    VA I01BX003934Oct 1, 2017 - Sep 30, 2021
    Role: Principal Investigator
    Role of Chromogranin A in Metabolic Syndrome
    VA I01BX000323Apr 1, 2010 - Mar 31, 2014
    Role: Principal Investigator
    Chromaffin Cell physiology: Novel molecular approaches
    NIH/NIDA R01DA011311Sep 30, 1997 - Mar 31, 2011
    Role: Principal Investigator
    CHROMOGRANIN A--NICOTINIC SIGNALING AND DESENSITIZATION
    NIH/NIDA R29DA011311Sep 30, 1997 - Aug 31, 2003
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mahata SK, Corti A. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation. Ann N Y Acad Sci. 2019 Oct 06. PMID: 31588572.
      View in: PubMed
    2. Sahu BS, Rodriguez P, Nguyen ME, Han R, Cero C, Razzoli M, Piaggi P, Laskowski LJ, Pavlicev M, Muglia L, Mahata SK, O'Grady S, McCorvy JD, Baier LJ, Sham YY, Bartolomucci A. Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21. Cell Rep. 2019 Sep 03; 28(10):2567-2580.e6. PMID: 31484069.
      View in: PubMed
    3. Moore TM, Zhou Z, Cohn W, Norheim F, Lin AJ, Kalajian N, Strumwasser AR, Cory K, Whitney K, Ho T, Ho T, Lee JL, Rucker DH, Shirihai O, van der Bliek AM, Whitelegge JP, Seldin MM, Lusis AJ, Lee S, Drevon CA, Mahata SK, Turcotte LP, Hevener AL. The impact of exercise on mitochondrial dynamics and the role of Drp1 in exercise performance and training adaptations in skeletal muscle. Mol Metab. 2019 03; 21:51-67. PMID: 30591411.
      View in: PubMed
    4. Sahu BS, Mahata S, Bandyopadhyay K, Mahata M, Avolio E, Pasqua T, Sahu C, Bandyopadhyay GK, Bartolomucci A, Webster NJG, Van Den Bogaart G, Fischer-Colbrie R, Corti A, Eiden LE, Mahata SK. Catestatin regulates vesicular quanta through modulation of cholinergic and peptidergic (PACAPergic) stimulation in PC12 cells. Cell Tissue Res. 2019 Apr; 376(1):51-70. PMID: 30467710.
      View in: PubMed
    5. Muntjewerff EM, Dunkel G, Nicolasen MJT, Mahata SK, van den Bogaart G. Catestatin as a Target for Treatment of Inflammatory Diseases. Front Immunol. 2018; 9:2199. PMID: 30337922.
      View in: PubMed
    6. McWherter C, Choi YJ, Serrano RL, Mahata SK, Terkeltaub R, Liu-Bryan R. Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling. Arthritis Res Ther. 2018 09 06; 20(1):204. PMID: 30189890.
      View in: PubMed
    7. Jati S, Kundu S, Chakraborty A, Mahata SK, Nizet V, Sen M. Wnt5A Signaling Promotes Defense Against Bacterial Pathogens by Activating a Host Autophagy Circuit. Front Immunol. 2018; 9:679. PMID: 29686674.
      View in: PubMed
    8. Pearn ML, Schilling JM, Jian M, Egawa J, Wu C, Mandyam CD, Fannon-Pavlich MJ, Nguyen U, Bertoglio J, Kodama M, Mahata SK, DerMardirossian C, Lemkuil BP, Han R, Mobley WC, Patel HH, Patel PM, Head BP. Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits. Br J Anaesth. 2018 Apr; 120(4):745-760. PMID: 29576115.
      View in: PubMed
    9. Ying W, Mahata S, Bandyopadhyay GK, Zhou Z, Wollam J, Vu J, Mayoral R, Chi NW, Webster NJG, Corti A, Mahata SK. Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity. Diabetes. 2018 05; 67(5):841-848. PMID: 29432123.
      View in: PubMed
    10. Hasan MK, Friedman TC, Sims C, Lee DL, Espinoza-Derout J, Ume A, Chalfant V, Lee ML, Sinha-Hikim I, Lutfy K, Liu Y, Mahata SK, Sinha-Hikim AP. a7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling. Endocrinology. 2018 02 01; 159(2):931-944. PMID: 29272360.
      View in: PubMed
    11. Zhou Z, Ribas V, Rajbhandari P, Drew BG, Moore TM, Fluitt AH, Reddish BR, Whitney KA, Georgia S, Vergnes L, Reue K, Liesa M, Shirihai O, van der Bliek AM, Chi NW, Mahata SK, Tiano JP, Hewitt SC, Tontonoz P, Korach KS, Mauvais-Jarvis F, Hevener AL. Estrogen receptor a protects pancreatic ß-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stress. J Biol Chem. 2018 03 30; 293(13):4735-4751. PMID: 29378845.
      View in: PubMed
    12. Sinha-Hikim AP, Mahata SK. Editorial: Obesity, Smoking, and Fatty Liver Disease. Front Endocrinol (Lausanne). 2018; 9:1. PMID: 29403440.
      View in: PubMed
    13. Mahata SK, Kiranmayi M, Mahapatra NR. Catestatin: A Master Regulator of Cardiovascular Functions. Curr Med Chem. 2018; 25(11):1352-1374. PMID: 28443506.
      View in: PubMed
    14. Sahu BS, Manna PT, Edgar JR, Antrobus R, Mahata SK, Bartolomucci A, Borner GHH, Robinson MS. Role of clathrin in dense core vesicle biogenesis. Mol Biol Cell. 2017 Oct 01; 28(20):2676-2685. PMID: 28814506.
      View in: PubMed
    15. Chakraborty A, Kurati SP, Mahata SK, Sundar S, Roy S, Sen M. Wnt5a Signaling Promotes Host Defense against Leishmania donovani Infection. J Immunol. 2017 08 01; 199(3):992-1002. PMID: 28659356.
      View in: PubMed
    16. Mishra PK, Ying W, Nandi SS, Bandyopadhyay GK, Patel KK, Mahata SK. Diabetic Cardiomyopathy: An Immunometabolic Perspective. Front Endocrinol (Lausanne). 2017; 8:72. PMID: 28439258.
      View in: PubMed
    17. Wollam J, Mahata S, Riopel M, Hernandez-Carretero A, Biswas A, Bandyopadhyay GK, Chi NW, Eiden LE, Mahapatra NR, Corti A, Webster NJG, Mahata SK. Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion. Cell Tissue Res. 2017 06; 368(3):487-501. PMID: 28220294.
      View in: PubMed
    18. Bandyopadhyay GK, Mahata SK. Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity. Front Endocrinol (Lausanne). 2017; 8:20. PMID: 28228748.
      View in: PubMed
    19. Ray I, Mahata SK, De RK. Obesity: An Immunometabolic Perspective. Front Endocrinol (Lausanne). 2016; 7:157. PMID: 28018292.
      View in: PubMed
    20. Mayoral Monibas R, Johnson AM, Osborn O, Traves PG, Mahata SK. Distinct Hepatic Macrophage Populations in Lean and Obese Mice. Front Endocrinol (Lausanne). 2016; 7:152. PMID: 27999564.
      View in: PubMed
    21. Sinha-Hikim I, Friedman TC, Falz M, Chalfant V, Hasan MK, Espinoza-Derout J, Lee DL, Sims C, Tran P, Mahata SK, Sinha-Hikim AP. Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis. Cell Tissue Res. 2017 04; 368(1):159-170. PMID: 27917437.
      View in: PubMed
    22. Curnis F, Dallatomasina A, Bianco M, Gasparri A, Sacchi A, Colombo B, Fiocchi M, Perani L, Venturini M, Tacchetti C, Sen S, Borges R, Dondossola E, Esposito A, Mahata SK, Corti A. Regulation of tumor growth by circulating full-length chromogranin A. Oncotarget. 2016 Nov 08; 7(45):72716-72732. PMID: 27683038.
      View in: PubMed
    23. Tang K, Pasqua T, Biswas A, Mahata S, Tang J, Tang A, Bandyopadhyay GK, Sinha-Hikim AP, Chi NW, Webster NJ, Corti A, Mahata SK. Muscle injury, impaired muscle function and insulin resistance in Chromogranin A-knockout mice. J Endocrinol. 2017 02; 232(2):137-153. PMID: 27799464.
      View in: PubMed
    24. Mahata SK, Zheng H, Mahata S, Liu X, Patel KP. Effect of heart failure on catecholamine granule morphology and storage in chromaffin cells. J Endocrinol. 2016 09; 230(3):309-23. PMID: 27402067.
      View in: PubMed
    25. Sen S, Roy S, Bandyopadhyay G, Scott B, Xiao D, Ramadoss S, Mahata SK, Chaudhuri G. ?-Aminobutyric Acid Is Synthesized and Released by the Endothelium: Potential Implications. Circ Res. 2016 Aug 19; 119(5):621-34. PMID: 27354210.
      View in: PubMed
    26. Sen S, Kawahara B, Mahata SK, Tsai R, Yoon A, Hwang L, Hu-Moore K, Villanueva C, Vajihuddin A, Parameshwar P, You M, Bhaskar DL, Gomez O, Faull KF, Farias-Eisner R, Chaudhuri G. Cystathionine: A novel oncometabolite in human breast cancer. Arch Biochem Biophys. 2016 08 15; 604:95-102. PMID: 27311614.
      View in: PubMed
    27. Patra M, Mahata SK, Padhan DK, Sen M. CCN6 regulates mitochondrial function. J Cell Sci. 2016 07 15; 129(14):2841-51. PMID: 27252383.
      View in: PubMed
    28. Biswas N, Maihofer AX, Mir SA, Rao F, Zhang K, Khandrika S, Mahata M, Friese RS, Hightower CM, Mahata SK, Baker DG, Nievergelt CM, Vaingankar SM, O'Connor DT. Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system. BMC Med Genet. 2016 Mar 11; 17:21. PMID: 26969407.
      View in: PubMed
    29. Pasqua T, Mahata S, Bandyopadhyay GK, Biswas A, Perkins GA, Sinha-Hikim AP, Goldstein DS, Eiden LE, Mahata SK. Erratum to: Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo. Cell Tissue Res. 2016 Mar; 363(3):823. PMID: 26809511.
      View in: PubMed
    30. Zhong L, Ding Y, Bandyopadhyay G, Waaler J, Börgeson E, Smith S, Zhang M, Phillips SA, Mahooti S, Mahata SK, Shao J, Krauss S, Chi NW. The PARsylation activity of tankyrase in adipose tissue modulates systemic glucose metabolism in mice. Diabetologia. 2016 Mar; 59(3):582-91. PMID: 26631215.
      View in: PubMed
    31. Pasqua T, Mahata S, Bandyopadhyay GK, Biswas A, Perkins GA, Sinha-Hikim AP, Goldstein DS, Eiden LE, Mahata SK. Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo. Cell Tissue Res. 2016 Mar; 363(3):693-712. PMID: 26572539.
      View in: PubMed
    32. Dominguez Rieg JA, Chirasani VR, Koepsell H, Senapati S, Mahata SK, Rieg T. Regulation of intestinal SGLT1 by catestatin in hyperleptinemic type 2 diabetic mice. Lab Invest. 2016 Jan; 96(1):98-111. PMID: 26552046.
      View in: PubMed
    33. Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F, Rocca C, Mahata SK, Gattuso A, Cerra MC. The NO stimulator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts. Nitric Oxide. 2015 11 15; 50:10-19. PMID: 26241941.
      View in: PubMed
    34. Fargali S, Garcia AL, Sadahiro M, Jiang C, Janssen WG, Lin WJ, Cogliani V, Elste A, Mortillo S, Cero C, Veitenheimer B, Graiani G, Pasinetti GM, Mahata SK, Osborn JW, Huntley GW, Phillips GR, Benson DL, Bartolomucci A, Salton SR. Erratum. The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure. FASEB J. 2015 Jun; 29(6):2679. PMID: 26032479.
      View in: PubMed
    35. Zhong L, Yeh TY, Hao J, Pourtabatabaei N, Mahata SK, Shao J, Chessler SD, Chi NW. Nutritional energy stimulates NAD+ production to promote tankyrase-mediated PARsylation in insulinoma cells. PLoS One. 2015; 10(4):e0122948. PMID: 25876076.
      View in: PubMed
    36. Zhang K, Mir SA, Hightower CM, Miramontes-Gonzalez JP, Maihofer AX, Chen Y, Mahata SK, Nievergelt CM, Schork NJ, Freedman BI, Vaingankar SM, O'Connor DT. Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107. J Am Soc Nephrol. 2015 Aug; 26(8):1816-25. PMID: 25392232.
      View in: PubMed
    37. Penna C, Pasqua T, Amelio D, Perrelli MG, Angotti C, Tullio F, Mahata SK, Tota B, Pagliaro P, Cerra MC, Angelone T. Catestatin increases the expression of anti-apoptotic and pro-angiogenetic factors in the post-ischemic hypertrophied heart of SHR. PLoS One. 2014; 9(8):e102536. PMID: 25099124.
      View in: PubMed
    38. Vu CU, Siddiqui JA, Wadensweiler P, Gayen JR, Avolio E, Bandyopadhyay GK, Biswas N, Chi NW, O'Connor DT, Mahata SK. Nicotinic acetylcholine receptors in glucose homeostasis: the acute hyperglycemic and chronic insulin-sensitive effects of nicotine suggest dual opposing roles of the receptors in male mice. Endocrinology. 2014 Oct; 155(10):3793-805. PMID: 25051446.
      View in: PubMed
    39. Bandyopadhyay GK, Lu M, Avolio E, Siddiqui JA, Gayen JR, Wollam J, Vu CU, Chi NW, O'Connor DT, Mahata SK. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance. Diabetes. 2015 Jan; 64(1):104-16. PMID: 25048197.
      View in: PubMed
    40. Fornero S, Bassino E, Ramella R, Gallina C, Mahata SK, Tota B, Levi R, Alloatti G, Gallo MP. Obligatory role for endothelial heparan sulphate proteoglycans and caveolae internalization in catestatin-dependent eNOS activation. Biomed Res Int. 2014; 2014:783623. PMID: 25136621.
      View in: PubMed
    41. Avolio E, Mahata SK, Mantuano E, Mele M, Alò R, Facciolo RM, Talani G, Canonaco M. Antihypertensive and neuroprotective effects of catestatin in spontaneously hypertensive rats: interaction with GABAergic transmission in amygdala and brainstem. Neuroscience. 2014 Jun 13; 270:48-57. PMID: 24731867.
      View in: PubMed
    42. Mele M, Avolio E, Alò R, Fazzari G, Mahata SK, Canonaco M. Catestatin and orexin-A neuronal signals alter feeding habits in relation to hibernating states. Neuroscience. 2014 Jun 06; 269:331-42. PMID: 24721733.
      View in: PubMed
    43. Fargali S, Garcia AL, Sadahiro M, Jiang C, Janssen WG, Lin WJ, Cogliani V, Elste A, Mortillo S, Cero C, Veitenheimer B, Graiani G, Pasinetti GM, Mahata SK, Osborn JW, Huntley GW, Phillips GR, Benson DL, Bartolomucci A, Salton SR. The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure. FASEB J. 2014 May; 28(5):2120-33. PMID: 24497580.
      View in: PubMed
    44. Biswas N, Friese RS, Gayen JR, Bandyopadhyay G, Mahata SK, O'Connor DT. Discovery of a novel target for the dysglycemic chromogranin A fragment pancreastatin: interaction with the chaperone GRP78 to influence metabolism. PLoS One. 2014; 9(1):e84132. PMID: 24465394.
      View in: PubMed
    45. Zhang K, Biswas N, Gayen JR, Miramontes-Gonzalez JP, Hightower CM, Mustapic M, Mahata M, Huang CT, Hook VY, Mahata SK, Vaingankar S, O'Connor DT. Chromogranin B: intra- and extra-cellular mechanisms to regulate catecholamine storage and release, in catecholaminergic cells and organisms. J Neurochem. 2014 Apr; 129(1):48-59. PMID: 24266713.
      View in: PubMed
    46. Valicherla GR, Hossain Z, Mahata SK, Gayen JR. Pancreastatin is an endogenous peptide that regulates glucose homeostasis. Physiol Genomics. 2013 Nov 15; 45(22):1060-71. PMID: 24064537.
      View in: PubMed
    47. Avolio E, Facciolo RM, Alò R, Mele M, Carelli A, Canonaco A, Mosciaro L, Talani G, Biggio G, Sanna E, Mahata SK, Canonaco M. Expression variations of chromogranin A and a1,2,4 GABA(A)Rs in discrete limbic and brainstem areas rescue cardiovascular alterations. Neurosci Res. 2013 Sep-Oct; 77(1-2):8-15. PMID: 23916832.
      View in: PubMed
    48. Tsigelny IF, Kouznetsova VL, Biswas N, Mahata SK, O'Connor DT. Development of a pharmacophore model for the catecholamine release-inhibitory peptide catestatin: virtual screening and functional testing identify novel small molecule therapeutics of hypertension. Bioorg Med Chem. 2013 Sep 15; 21(18):5855-69. PMID: 23916146.
      View in: PubMed
    49. Friese RS, Altshuler AE, Zhang K, Miramontes-Gonzalez JP, Hightower CM, Jirout ML, Salem RM, Gayen JR, Mahapatra NR, Biswas N, Cale M, Vaingankar SM, Kim HS, Courel M, Taupenot L, Ziegler MG, Schork NJ, Pravenec M, Mahata SK, Schmid-Schönbein GW, O'Connor DT. MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension. Hum Mol Genet. 2013 Sep 15; 22(18):3624-40. PMID: 23674521.
      View in: PubMed
    50. Borges R, Dominguez N, Smith CB, Bandyopadhyay GK, O'Connor DT, Mahata SK, Bartolomucci A. Granins and catecholamines: functional interaction in chromaffin cells and adipose tissue. Adv Pharmacol. 2013; 68:93-113. PMID: 24054141.
      View in: PubMed
    51. Wei Z, Zhang K, Wen G, Balasubramanian K, Shih PA, Rao F, Friese RS, Miramontes-Gonzalez JP, Schmid-Schoenbein GW, Kim HS, Mahata SK, O'Connor DT. Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs. J Hypertens. 2013 Jan; 31(1):123-33. PMID: 23149563.
      View in: PubMed
    52. Biswas N, Gayen J, Mahata M, Su Y, Mahata SK, O'Connor DT. Novel peptide isomer strategy for stable inhibition of catecholamine release: application to hypertension. Hypertension. 2012 Dec; 60(6):1552-9. PMID: 23129699.
      View in: PubMed
    53. Mbewe-Campbell N, Wei Z, Zhang K, Friese RS, Mahata M, Schork AJ, Rao F, Chiron S, Biswas N, Kim HS, Mahata SK, Waalen J, Nievergelt CM, Hook VY, O'Connor DT. Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure. J Hypertens. 2012 Oct; 30(10):1961-9. PMID: 22871890.
      View in: PubMed
    54. Bandyopadhyay GK, Vu CU, Gentile S, Lee H, Biswas N, Chi NW, O'Connor DT, Mahata SK. Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling. J Biol Chem. 2012 Jun 29; 287(27):23141-51. PMID: 22535963.
      View in: PubMed
    55. Loh YP, Cheng Y, Mahata SK, Corti A, Tota B. Chromogranin A and derived peptides in health and disease. J Mol Neurosci. 2012 Oct; 48(2):347-56. PMID: 22388654.
      View in: PubMed
    56. Mir SA, Chatterjee A, Mitra A, Pathak K, Mahata SK, Sarkar S. Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J Biol Chem. 2012 Jan 20; 287(4):2666-77. PMID: 22157761.
      View in: PubMed
    57. Angelone T, Quintieri AM, Pasqua T, Gentile S, Tota B, Mahata SK, Cerra MC. Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin. Am J Physiol Heart Circ Physiol. 2012 Jan; 302(2):H431-42. PMID: 22058158.
      View in: PubMed
    58. Rao F, Chiron S, Wei Z, Fung MM, Chen Y, Wen G, Khandrika S, Ziegler MG, Benyamin B, Montgomery G, Whitfield JB, Martin NG, Waalen J, Hamilton BA, Mahata SK, O'Connor DT. Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins. Am J Hypertens. 2012 Jan; 25(1):29-40. PMID: 21918574.
      View in: PubMed
    59. Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SR. The extended granin family: structure, function, and biomedical implications. Endocr Rev. 2011 Dec; 32(6):755-97. PMID: 21862681.
      View in: PubMed
    60. Sinha-Hikim I, Shen R, Nzenwa I, Gelfand R, Mahata SK, Sinha-Hikim AP. Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis. 2011 Jun; 16(6):563-73. PMID: 21424555.
      View in: PubMed
    61. Mahata M, Zhang K, Gayen JR, Nandi S, Brar BK, Ghosh S, Mahapatra NR, Taupenot L, O'Connor DT, Mahata SK. Catecholamine biosynthesis and secretion: physiological and pharmacological effects of secretin. Cell Tissue Res. 2011 Jul; 345(1):87-102. PMID: 21597914.
      View in: PubMed
    62. Chiron S, Wei Z, Chen Y, Zhang K, Wen G, Fischer WH, Mahata SK, O'Connor DT. Proteomic analysis yields an unexpected trans-acting point in control of the human sympathochromaffin phenotype. Circ Cardiovasc Genet. 2011 Aug 01; 4(4):437-45. PMID: 21551321.
      View in: PubMed
    63. Bassino E, Fornero S, Gallo MP, Ramella R, Mahata SK, Tota B, Levi R, Alloatti G. A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium. Cardiovasc Res. 2011 Sep 01; 91(4):617-24. PMID: 21543385.
      View in: PubMed
    64. Lu M, Sarruf DA, Talukdar S, Sharma S, Li P, Bandyopadhyay G, Nalbandian S, Fan W, Gayen JR, Mahata SK, Webster NJ, Schwartz MW, Olefsky JM. Brain PPAR-? promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nat Med. 2011 May; 17(5):618-22. PMID: 21532596.
      View in: PubMed
    65. Zhang K, Chen Y, Wen G, Mahata M, Rao F, Fung MM, Vaingankar S, Biswas N, Gayen JR, Friese RS, Mahata SK, Hamilton BA, O'Connor DT. Catecholamine storage vesicles: role of core protein genetic polymorphisms in hypertension. Curr Hypertens Rep. 2011 Feb; 13(1):36-45. PMID: 21104344.
      View in: PubMed
    66. Penna C, Alloatti G, Gallo MP, Cerra MC, Levi R, Tullio F, Bassino E, Dolgetta S, Mahata SK, Tota B, Pagliaro P. Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart. Cell Mol Neurobiol. 2010 Nov; 30(8):1171-9. PMID: 21104119.
      View in: PubMed
    67. Biswas N, Curello E, O'Connor DT, Mahata SK. Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384)). Cell Tissue Res. 2010 Dec; 342(3):353-61. PMID: 21052719.
      View in: PubMed
    68. Imbrogno S, Garofalo F, Cerra MC, Mahata SK, Tota B. The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish. J Exp Biol. 2010 Nov 01; 213(Pt 21):3636-43. PMID: 20952611.
      View in: PubMed
    69. Chen Y, Rao F, Wen G, Gayen JR, Zhang K, Vaingankar SM, Biswas N, Mahata M, Friese RS, Fung MM, Salem RM, Nievergelt C, Bhatnagar V, Hook VY, Ziegler MG, Mahata SK, Hamilton BA, O'Connor DT. Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease. Cell Mol Neurobiol. 2010 Nov; 30(8):1395-400. PMID: 21061160.
      View in: PubMed
    70. Mahata SK, Mahata M, Fung MM, O'Connor DT. Reprint of: Catestatin: a multifunctional peptide from chromogranin A. Regul Pept. 2010 Nov 30; 165(1):52-62. PMID: 20965217.
      View in: PubMed
    71. Theurl M, Schgoer W, Albrecht K, Jeschke J, Egger M, Beer AG, Vasiljevic D, Rong S, Wolf AM, Bahlmann FH, Patsch JR, Wolf D, Schratzberger P, Mahata SK, Kirchmair R. The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism. Circ Res. 2010 Nov 26; 107(11):1326-35. PMID: 20930149.
      View in: PubMed
    72. Chen Y, Salem RM, Rao F, Fung MM, Bhatnagar V, Pandey B, Mahata M, Waalen J, Nievergelt CM, Lipkowitz MS, Hamilton BA, Mahata SK, O'Connor DT. Common charge-shift mutation Glu65Lys in K+ channel ß1-Subunit KCNMB1: pleiotropic consequences for glomerular filtration rate and progressive renal disease. Am J Nephrol. 2010; 32(5):414-24. PMID: 20861615.
      View in: PubMed
    73. Fung MM, Rao F, Poddar S, Mahata M, Khandrika S, Mahata SK, O'Connor DT. Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects. Am J Hypertens. 2011 Feb; 24(2):225-33. PMID: 20864943.
      View in: PubMed
    74. Chen Y, Zhang K, Wen G, Rao F, Sanchez AP, Wang L, Rodriguez-Flores JL, Mahata M, Mahata SK, Waalen J, Ziegler MG, Hamilton BA, O'Connor DT. Human dopamine ß-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure. Am J Hypertens. 2011 Jan; 24(1):24-32. PMID: 20814407.
      View in: PubMed
    75. Gayen JR, Zhang K, RamachandraRao SP, Mahata M, Chen Y, Kim HS, Naviaux RK, Sharma K, Mahata SK, O'Connor DT. Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene. Circ Cardiovasc Genet. 2010 Oct; 3(5):414-25. PMID: 20729505.
      View in: PubMed
    76. Gu Y, Zhang K, Biswas N, Friese RS, Lin DH, Mahata SK, Hoshijima M, O'Connor DT, Peterson KL, Brar BK. Urocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity. Endocrinology. 2010 Oct; 151(10):4820-9. PMID: 20668031.
      View in: PubMed
    77. Brar BK, Helgeland E, Mahata SK, Zhang K, O'Connor DT, Helle KB, Jonassen AK. Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart. Regul Pept. 2010 Nov 30; 165(1):63-70. PMID: 20655339.
      View in: PubMed
    78. Chen Y, Lipkowitz MS, Salem RM, Fung MM, Bhatnagar V, Mahata M, Nievergelt CM, Rao F, Mahata SK, Schork NJ, Hicks PJ, Bowden DW, Freedman BI, Brophy VH, O'Connor DT. Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis. Am J Nephrol. 2010; 32(1):23-30. PMID: 20484896.
      View in: PubMed
    79. Radek KA, Elias PM, Taupenot L, Mahata SK, O'Connor DT, Gallo RL. Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production. Cell Host Microbe. 2010 Apr 22; 7(4):277-89. PMID: 20413096.
      View in: PubMed
    80. Dev NB, Gayen JR, O'Connor DT, Mahata SK. Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment. Endocrinology. 2010 Jun; 151(6):2760-8. PMID: 20410203.
      View in: PubMed
    81. Jirout ML, Friese RS, Mahapatra NR, Mahata M, Taupenot L, Mahata SK, Kren V, Zídek V, Fischer J, Maatz H, Ziegler MG, Pravenec M, Hubner N, Aitman TJ, Schork NJ, O'Connor DT. Genetic regulation of catecholamine synthesis, storage and secretion in the spontaneously hypertensive rat. Hum Mol Genet. 2010 Jul 01; 19(13):2567-80. PMID: 20378607.
      View in: PubMed
    82. Zhang K, Rao F, Wang L, Rana BK, Ghosh S, Mahata M, Salem RM, Rodriguez-Flores JL, Fung MM, Waalen J, Tayo B, Taupenot L, Mahata SK, O'Connor DT. Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension. J Am Coll Cardiol. 2010 Apr 06; 55(14):1463-75. PMID: 20359597.
      View in: PubMed
    83. Vaingankar SM, Li Y, Biswas N, Gayen J, Choksi S, Rao F, Ziegler MG, Mahata SK, O'Connor DT. Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses. J Hypertens. 2010 Apr; 28(4):817-25. PMID: 20139771.
      View in: PubMed
    84. Rodríguez-Flores JL, Zhang K, Kang SW, Wen G, Ghosh S, Friese RS, Mahata SK, Subramaniam S, Hamilton BA, O'Connor DT. Conserved regulatory motifs at phenylethanolamine N-methyltransferase (PNMT) are disrupted by common functional genetic variation: an integrated computational/experimental approach. Mamm Genome. 2010 Apr; 21(3-4):195-204. PMID: 20204374.
      View in: PubMed
    85. Stadinski BD, Delong T, Reisdorph N, Reisdorph R, Powell RL, Armstrong M, Piganelli JD, Barbour G, Bradley B, Crawford F, Marrack P, Mahata SK, Kappler JW, Haskins K. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol. 2010 Mar; 11(3):225-31. PMID: 20139986.
      View in: PubMed
    86. Mahata SK, Mahata M, Fung MM, O'Connor DT. Catestatin: a multifunctional peptide from chromogranin A. Regul Pept. 2010 Jun 08; 162(1-3):33-43. PMID: 20116404.
      View in: PubMed
    87. Alam A, O'Connor DT, Perianayagam MC, Kolyada AY, Chen Y, Rao F, Mahata M, Mahata S, Liangos O, Jaber BL. Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury. Nephron Clin Pract. 2010; 114(4):c253-9. PMID: 20090367.
      View in: PubMed
    88. Courel M, Soler-Jover A, Rodriguez-Flores JL, Mahata SK, Elias S, Montero-Hadjadje M, Anouar Y, Giuly RJ, O'Connor DT, Taupenot L. Pro-hormone secretogranin II regulates dense core secretory granule biogenesis in catecholaminergic cells. J Biol Chem. 2010 Mar 26; 285(13):10030-43. PMID: 20061385.
      View in: PubMed
    89. Fung MM, Salem RM, Mehtani P, Thomas B, Lu CF, Perez B, Rao F, Stridsberg M, Ziegler MG, Mahata SK, O'Connor DT. Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo. Clin Exp Hypertens. 2010; 32(5):278-87. PMID: 20662728.
      View in: PubMed
    90. Chen Y, Wen G, Rao F, Zhang K, Wang L, Rodriguez-Flores JL, Sanchez AP, Mahata M, Taupenot L, Sun P, Mahata SK, Tayo B, Schork NJ, Ziegler MG, Hamilton BA, O'Connor DT. Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. J Hypertens. 2010 Jan; 28(1):76-86. PMID: 20009769.
      View in: PubMed
    91. Schafer MK, Mahata SK, Stroth N, Eiden LE, Weihe E. Cellular distribution of chromogranin A in excitatory, inhibitory, aminergic and peptidergic neurons of the rodent central nervous system. Regul Pept. 2010 Nov 30; 165(1):36-44. PMID: 20005907.
      View in: PubMed
    92. Vaingankar SM, Li Y, Corti A, Biswas N, Gayen J, O'Connor DT, Mahata SK. Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout. Physiol Genomics. 2010 Mar 03; 41(1):91-101. PMID: 20009010.
      View in: PubMed
    93. Friese RS, Gayen JR, Mahapatra NR, Schmid-Schönbein GW, O'Connor DT, Mahata SK. Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification. Physiol Genomics. 2010 Feb 04; 40(3):195-207. PMID: 19952279.
      View in: PubMed
    94. Shih PB, Wang L, Chiron S, Wen G, Nievergelt C, Mahata M, Khandrika S, Rao F, Fung MM, Mahata SK, Hamilton BA, O'Connor DT. Peptide YY (PYY) Gene Polymorphisms in the 3'-Untranslated Region and Proximal Promoter Regions Regulate Cellular Gene Expression and PYY Secretion and Metabolic Syndrome Traits in Vivo. Endocr Rev. 2009 Dec 01; 30(7):934. PMID: 28199513.
      View in: PubMed
    95. Gayen JR, Gu Y, O'Connor DT, Mahata SK. Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse. Endocrinology. 2009 Nov; 150(11):5027-35. PMID: 19819970.
      View in: PubMed
    96. Shih PA, Wang L, Chiron S, Wen G, Nievergelt C, Mahata M, Khandrika S, Rao F, Fung MM, Mahata SK, Hamilton BA, O'Connor DT. Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo. J Clin Endocrinol Metab. 2009 Nov; 94(11):4557-66. PMID: 19820027.
      View in: PubMed
    97. Fung MM, Chen Y, Lipkowitz MS, Salem RM, Bhatnagar V, Mahata M, Nievergelt CM, Rao F, Mahata SK, Schork NJ, Brophy VH, O'Connor DT. Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis. Nephrol Dial Transplant. 2009 Dec; 24(12):3677-86. PMID: 19745105.
      View in: PubMed
    98. Wang L, Rao F, Zhang K, Mahata M, Rodriguez-Flores JL, Fung MM, Waalen J, Cockburn MG, Hamilton BA, Mahata SK, O'Connor DT. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J Am Coll Cardiol. 2009 Sep 01; 54(10):944-54. PMID: 19712806.
      View in: PubMed
    99. Gayen JR, Saberi M, Schenk S, Biswas N, Vaingankar SM, Cheung WW, Najjar SM, O'Connor DT, Bandyopadhyay G, Mahata SK. A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis. J Biol Chem. 2009 Oct 16; 284(42):28498-509. PMID: 19706599.
      View in: PubMed
    100. Rana BK, Wessel J, Mahboubi V, Rao F, Haeller J, Gayen JR, Eskin E, Valle AM, Das M, Mahata SK, Taupenot L, Stridsberg M, Talley TT, Ziegler MG, Smith DW, Schork NJ, O'Connor DT, Taylor P. Natural variation within the neuronal nicotinic acetylcholine receptor cluster on human chromosome 15q24: influence on heritable autonomic traits in twin pairs. J Pharmacol Exp Ther. 2009 Nov; 331(2):419-28. PMID: 19671882.
      View in: PubMed
    101. Chen Y, Mahata M, Rao F, Khandrika S, Courel M, Fung MM, Zhang K, Stridsberg M, Ziegler MG, Hamilton BA, Lipkowitz MS, Taupenot L, Nievergelt C, Mahata SK, O'Connor DT. Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis. J Am Soc Nephrol. 2009 Jul; 20(7):1623-32. PMID: 19520754.
      View in: PubMed
    102. Biswas N, Rodriguez-Flores JL, Courel M, Gayen JR, Vaingankar SM, Mahata M, Torpey JW, Taupenot L, O'Connor DT, Mahata SK. Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides. Endocrinology. 2009 Aug; 150(8):3547-57. PMID: 19372204.
      View in: PubMed
    103. Zhang K, Rao F, Rana BK, Gayen JR, Calegari F, King A, Rosa P, Huttner WB, Stridsberg M, Mahata M, Vaingankar S, Mahboubi V, Salem RM, Rodriguez-Flores JL, Fung MM, Smith DW, Schork NJ, Ziegler MG, Taupenot L, Mahata SK, O'Connor DT. Autonomic function in hypertension; role of genetic variation at the catecholamine storage vesicle protein chromogranin B. Circ Cardiovasc Genet. 2009 Feb; 2(1):46-56. PMID: 20011129.
      View in: PubMed
    104. Rao F, Zhang L, Wessel J, Zhang K, Wen G, Kennedy BP, Rana BK, Das M, Rodriguez-Flores JL, Smith DW, Cadman PE, Salem RM, Mahata SK, Schork NJ, Taupenot L, Ziegler MG, O'Connor DT. Adrenergic polymorphism and the human stress response. Ann N Y Acad Sci. 2008 Dec; 1148:282-96. PMID: 19120120.
      View in: PubMed
    105. Sheikh F, Raskin A, Chu PH, Lange S, Domenighetti AA, Zheng M, Liang X, Zhang T, Yajima T, Gu Y, Dalton ND, Mahata SK, Dorn GW, Brown JH, Heller-Brown J, Peterson KL, Omens JH, McCulloch AD, Chen J. An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J Clin Invest. 2008 Dec; 118(12):3870-80. PMID: 19033658.
      View in: PubMed
    106. Chen Y, Rao F, Rodriguez-Flores JL, Mahata M, Fung MM, Stridsberg M, Vaingankar SM, Wen G, Salem RM, Das M, Cockburn MG, Schork NJ, Ziegler MG, Hamilton BA, Mahata SK, Taupenot L, O'Connor DT. Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion. J Am Coll Cardiol. 2008 Oct 28; 52(18):1468-81. PMID: 19017515.
      View in: PubMed
    107. Egger M, Beer AG, Theurl M, Schgoer W, Hotter B, Tatarczyk T, Vasiljevic D, Frauscher S, Marksteiner J, Patsch JR, Schratzberger P, Djanani AM, Mahata SK, Kirchmair R. Monocyte migration: a novel effect and signaling pathways of catestatin. Eur J Pharmacol. 2008 Nov 19; 598(1-3):104-11. PMID: 18834877.
      View in: PubMed
    108. Portela-Gomes GM, Gayen JR, Grimelius L, Stridsberg M, Mahata SK. The importance of chromogranin A in the development and function of endocrine pancreas. Regul Pept. 2008 Nov 29; 151(1-3):19-25. PMID: 18722481.
      View in: PubMed
    109. O'Connor DT, Zhu G, Rao F, Taupenot L, Fung MM, Das M, Mahata SK, Mahata M, Wang L, Zhang K, Greenwood TA, Shih PA, Cockburn MG, Ziegler MG, Stridsberg M, Martin NG, Whitfield JB. Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure. Circulation. 2008 Jul 15; 118(3):247-57. PMID: 18591442.
      View in: PubMed
    110. Mahapatra NR, Taupenot L, Courel M, Mahata SK, O'Connor DT. The trans-Golgi proteins SCLIP and SCG10 interact with chromogranin A to regulate neuroendocrine secretion. Biochemistry. 2008 Jul 08; 47(27):7167-78. PMID: 18549247.
      View in: PubMed
    111. Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK, Cerra MC. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology. 2008 Oct; 149(10):4780-93. PMID: 18535098.
      View in: PubMed
    112. Vallon V, Eraly SA, Wikoff WR, Rieg T, Kaler G, Truong DM, Ahn SY, Mahapatra NR, Mahata SK, Gangoiti JA, Wu W, Barshop BA, Siuzdak G, Nigam SK. Organic anion transporter 3 contributes to the regulation of blood pressure. J Am Soc Nephrol. 2008 Sep; 19(9):1732-40. PMID: 18508962.
      View in: PubMed
    113. Mazza R, Gattuso A, Mannarino C, Brar BK, Barbieri SF, Tota B, Mahata SK. Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart. Am J Physiol Heart Circ Physiol. 2008 Jul; 295(1):H113-22. PMID: 18469147.
      View in: PubMed
    114. Chen Y, Rao F, Rodriguez-Flores JL, Mahapatra NR, Mahata M, Wen G, Salem RM, Shih PA, Das M, Schork NJ, Ziegler MG, Hamilton BA, Mahata SK, O'Connor DT. Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure. Kidney Int. 2008 Jul; 74(1):115-25. PMID: 18432188.
      View in: PubMed
    115. Montesinos MS, Machado JD, Camacho M, Diaz J, Morales YG, Alvarez de la Rosa D, Carmona E, Castañeyra A, Viveros OH, O'Connor DT, Mahata SK, Borges R. The crucial role of chromogranins in storage and exocytosis revealed using chromaffin cells from chromogranin A null mouse. J Neurosci. 2008 Mar 26; 28(13):3350-8. PMID: 18367602.
      View in: PubMed
    116. Willis M, Prokesch M, Hutter-Paier B, Windisch M, Stridsberg M, Mahata SK, Kirchmair R, Wietzorrek G, Knaus HG, Jellinger K, Humpel C, Marksteiner J. Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patients. J Alzheimers Dis. 2008 Mar; 13(2):123-35. PMID: 18376054.
      View in: PubMed
    117. Courel M, Vasquez MS, Hook VY, Mahata SK, Taupenot L. Sorting of the neuroendocrine secretory protein Secretogranin II into the regulated secretory pathway: role of N- and C-terminal alpha-helical domains. J Biol Chem. 2008 Apr 25; 283(17):11807-22. PMID: 18299326.
      View in: PubMed
    118. Salem RM, Cadman PE, Chen Y, Rao F, Wen G, Hamilton BA, Rana BK, Smith DW, Stridsberg M, Ward HJ, Mahata M, Mahata SK, Bowden DW, Hicks PJ, Freedman BI, Schork NJ, O'Connor DT. Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol. 2008 Mar; 19(3):600-14. PMID: 18235090.
      View in: PubMed
    119. Radek KA, Lopez-Garcia B, Hupe M, Niesman IR, Elias PM, Taupenot L, Mahata SK, O'Connor DT, Gallo RL. The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. J Invest Dermatol. 2008 Jun; 128(6):1525-34. PMID: 18185531.
      View in: PubMed
    120. Fung MM, Nguyen C, Mehtani P, Salem RM, Perez B, Thomas B, Das M, Schork NJ, Mahata SK, Ziegler MG, O'Connor DT. Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans. Circulation. 2008 Jan 29; 117(4):517-25. PMID: 18180394.
      View in: PubMed
    121. Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata SK, Anouar Y. Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf). 2008 Feb; 192(2):309-24. PMID: 18005393.
      View in: PubMed
    122. Biswas N, Vaingankar SM, Mahata M, Das M, Gayen JR, Taupenot L, Torpey JW, O'Connor DT, Mahata SK. Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin. Endocrinology. 2008 Feb; 149(2):749-57. PMID: 17991725.
      View in: PubMed
    123. Zhang L, Rao F, Zhang K, Khandrika S, Das M, Vaingankar SM, Bao X, Rana BK, Smith DW, Wessel J, Salem RM, Rodriguez-Flores JL, Mahata SK, Schork NJ, Ziegler MG, O'Connor DT. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. J Clin Invest. 2007 Sep; 117(9):2658-71. PMID: 17717598.
      View in: PubMed
    124. Mosley CA, Taupenot L, Biswas N, Taulane JP, Olson NH, Vaingankar SM, Wen G, Schork NJ, Ziegler MG, Mahata SK, O'Connor DT. Biogenesis of the secretory granule: chromogranin A coiled-coil structure results in unusual physical properties and suggests a mechanism for granule core condensation. Biochemistry. 2007 Sep 25; 46(38):10999-1012. PMID: 17718510.
      View in: PubMed
    125. Rao F, Zhang L, Wessel J, Zhang K, Wen G, Kennedy BP, Rana BK, Das M, Rodriguez-Flores JL, Smith DW, Cadman PE, Salem RM, Mahata SK, Schork NJ, Taupenot L, Ziegler MG, O'Connor DT. Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation. 2007 Aug 28; 116(9):993-1006. PMID: 17698732.
      View in: PubMed
    126. Wen G, Wessel J, Zhou W, Ehret GB, Rao F, Stridsberg M, Mahata SK, Gent PM, Das M, Cooper RS, Chakravarti A, Zhou H, Schork NJ, O'connor DT, Hamilton BA. An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension. Hum Mol Genet. 2007 Jul 15; 16(14):1752-64. PMID: 17584765.
      View in: PubMed
    127. Lillie EO, Mahata M, Khandrika S, Rao F, Bundey RA, Wen G, Chen Y, Taupenot L, Smith DW, Mahata SK, Ziegler MG, Cockburn M, Schork NJ, O'Connor DT. Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function. Circulation. 2007 May 01; 115(17):2282-91. PMID: 17438153.
      View in: PubMed
    128. Rao F, Wen G, Gayen JR, Das M, Vaingankar SM, Rana BK, Mahata M, Kennedy BP, Salem RM, Stridsberg M, Abel K, Smith DW, Eskin E, Schork NJ, Hamilton BA, Ziegler MG, Mahata SK, O'Connor DT. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation. 2007 May 01; 115(17):2271-81. PMID: 17438154.
      View in: PubMed
    129. O'Connor DT, Mahata SK, Mahata M, Jiang Q, Hook VY, Taupenot L. Primary culture of bovine chromaffin cells. Nat Protoc. 2007; 2(5):1248-53. PMID: 17546020.
      View in: PubMed
    130. Zhang K, Rao F, Wen G, Salem RM, Vaingankar S, Mahata M, Mahapatra NR, Lillie EO, Cadman PE, Friese RS, Hamilton BA, Hook VY, Mahata SK, Taupenot L, O'Connor DT. Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin. Diabetes Obes Metab. 2006 Nov; 8(6):621-33. PMID: 17026486.
      View in: PubMed
    131. Mahapatra NR, Mahata M, Ghosh S, Gayen JR, O'Connor DT, Mahata SK. Molecular basis of neuroendocrine cell type-specific expression of the chromogranin B gene: Crucial role of the transcription factors CREB, AP-2, Egr-1 and Sp1. J Neurochem. 2006 Oct; 99(1):119-33. PMID: 16987240.
      View in: PubMed
    132. Mahapatra NR, Mahata M, Mahata SK, O'Connor DT. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters. J Hypertens. 2006 May; 24(5):895-904. PMID: 16612252.
      View in: PubMed
    133. Greenwood TA, Rao F, Stridsberg M, Mahapatra NR, Mahata M, Lillie EO, Mahata SK, Taupenot L, Schork NJ, O'Connor DT. Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion. Physiol Genomics. 2006 May 16; 25(3):470-9. PMID: 16554546.
      View in: PubMed
    134. Nothacker HP, Wang Z, Zeng H, Mahata SK, O'Connor DT, Civelli O. Proadrenomedullin N-terminal peptide and cortistatin activation of MrgX2 receptor is based on a common structural motif. Eur J Pharmacol. 2005 Sep 05; 519(1-2):191-3. PMID: 16111673.
      View in: PubMed
    135. Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross J, Mahata SK. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest. 2005 Jul; 115(7):1942-52. PMID: 16007257.
      View in: PubMed
    136. O'Connor DT, Cadman PE, Smiley C, Salem RM, Rao F, Smith J, Funk SD, Mahata SK, Mahata M, Wen G, Taupenot L, Gonzalez-Yanes C, Harper KL, Henry RR, Sanchez-Margalet V. Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism. J Clin Endocrinol Metab. 2005 Sep; 90(9):5414-25. PMID: 15956083.
      View in: PubMed
    137. Friese RS, Mahboubi P, Mahapatra NR, Mahata SK, Schork NJ, Schmid-Schönbein GW, O'Connor DT. Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension. Am J Hypertens. 2005 May; 18(5 Pt 1):633-52. PMID: 15882546.
      View in: PubMed
    138. Briolat J, Wu SD, Mahata SK, Gonthier B, Bagnard D, Chasserot-Golaz S, Helle KB, Aunis D, Metz-Boutigue MH. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell Mol Life Sci. 2005 Feb; 62(3):377-85. PMID: 15723172.
      View in: PubMed
    139. Mahapatra NR, Mahata M, Hazra PP, McDonough PM, O'Connor DT, Mahata SK. A dynamic pool of calcium in catecholamine storage vesicles. Exploration in living cells by a novel vesicle-targeted chromogranin A-aequorin chimeric photoprotein. J Biol Chem. 2004 Dec 03; 279(49):51107-21. PMID: 15358782.
      View in: PubMed
    140. Mahata SK, Mahata M, Wen G, Wong WB, Mahapatra NR, Hamilton BA, O'Connor DT. The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses. Mol Pharmacol. 2004 Nov; 66(5):1180-91. PMID: 15326220.
      View in: PubMed
    141. Fries RS, Mahboubi P, Mahapatra NR, Mahata SK, Schork NJ, Schmid-Schoenbein GW, O'Connor DT. Neuroendocrine transcriptome in genetic hypertension: multiple changes in diverse adrenal physiological systems. Hypertension. 2004 Jun; 43(6):1301-11. PMID: 15166183.
      View in: PubMed
    142. Preece NE, Nguyen M, Mahata M, Mahata SK, Mahapatra NR, Tsigelny I, O'Connor DT. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A. Regul Pept. 2004 Apr 15; 118(1-2):75-87. PMID: 14759560.
      View in: PubMed
    143. Wen G, Mahata SK, Cadman P, Mahata M, Ghosh S, Mahapatra NR, Rao F, Stridsberg M, Smith DW, Mahboubi P, Schork NJ, O'Connor DT, Hamilton BA. Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet. 2004 Feb; 74(2):197-207. PMID: 14740315.
      View in: PubMed
    144. Prommegger R, Ensinger C, Adlassnig C, Vaingankar S, Mahata SK, Marksteiner J, Margreiter R. Catestatin--a novel neuropeptide in carcinoid tumors of the appendix. Anticancer Res. 2004 Jan-Feb; 24(1):311-6. PMID: 15015613.
      View in: PubMed
    145. Lechner T, Adlassnig C, Humpel C, Kaufmann WA, Maier H, Reinstadler-Kramer K, Hinterhölzl J, Mahata SK, Jellinger KA, Marksteiner J. Chromogranin peptides in Alzheimer's disease. Exp Gerontol. 2004 Jan; 39(1):101-13. PMID: 14724070.
      View in: PubMed
    146. Bitsche M, Mahata SK, Marksteiner J, Schrott-Fischer A. Distribution of catestatin-like immunoreactivity in the human auditory system. Hear Res. 2003 Oct; 184(1-2):16-26. PMID: 14553900.
      View in: PubMed
    147. Wong C, Mahapatra NR, Chitbangonsyn S, Mahboubi P, Mahata M, Mahata SK, O'Connor DT. The angiotensin II receptor (Agtr1a): functional regulatory polymorphisms in a locus genetically linked to blood pressure variation in the mouse. Physiol Genomics. 2003 Jun 24; 14(1):83-93. PMID: 12697907.
      View in: PubMed
    148. Lee JC, Taylor CV, Gaucher SP, Toneff T, Taupenot L, Yasothornsrikul S, Mahata SK, Sei C, Parmer RJ, Neveu JM, Lane WS, Gibson BW, O'Connor DT, Hook VY. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells. Biochemistry. 2003 Jun 17; 42(23):6938-46. PMID: 12795588.
      View in: PubMed
    149. Krüger PG, Mahata SK, Helle KB. Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides. Regul Pept. 2003 Jun 15; 114(1):29-35. PMID: 12763637.
      View in: PubMed
    150. Mahata SK, Mahapatra NR, Mahata M, Wang TC, Kennedy BP, Ziegler MG, O'Connor DT. Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin. J Biol Chem. 2003 Aug 22; 278(34):32058-67. PMID: 12799369.
      View in: PubMed
    151. Mahapatra NR, Mahata M, O'Connor DT, Mahata SK. Secretin activation of chromogranin A gene transcription. Identification of the signaling pathways in cis and in trans. J Biol Chem. 2003 May 30; 278(22):19986-94. PMID: 12646581.
      View in: PubMed
    152. Taupenot L, Harper KL, Mahapatra NR, Parmer RJ, Mahata SK, O'Connor DT. Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. J Cell Sci. 2002 Dec 15; 115(Pt 24):4827-41. PMID: 12432071.
      View in: PubMed
    153. Bao X, Kennedy B, Enns R, Mahata M, Mahata S, O'Connor D, Ziegler MG. A truncated mouse phenylethanolamine N-methyltransferase splice variant with dominant-negative activity. Ann N Y Acad Sci. 2002 Oct; 971:89-91. PMID: 12438096.
      View in: PubMed
    154. Laslop A, Mahata SK. Neuropeptides and chromogranins: session overview. Ann N Y Acad Sci. 2002 Oct; 971:294-9. PMID: 12438139.
      View in: PubMed
    155. Krüuger PG, Mahata SK, Helle KB. Catestatin (chromogranin A344-358) stimulates release of histamine from rat pleural and peritoneal mast cells. Ann N Y Acad Sci. 2002 Oct; 971:349-51. PMID: 12438149.
      View in: PubMed
    156. Cadman PE, Rao F, Mahata SK, O'Connor DT. Studies of the dysglycemic peptide, pancreastatin, using a human forearm model. Ann N Y Acad Sci. 2002 Oct; 971:528-9. PMID: 12438174.
      View in: PubMed
    157. Mahata SK, Mahapatra NR, Mahata M, O'Connor DT. Neuroendocrine cell type-specific and inducible expression of chromogranin/secretogranin genes: crucial promoter motifs. Ann N Y Acad Sci. 2002 Oct; 971:27-38. PMID: 12438085.
      View in: PubMed
    158. Mahata M, Mahapatra NR, O'Connor DT, Mahata SK. Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells. Mol Pharmacol. 2002 Jun; 61(6):1340-7. PMID: 12021395.
      View in: PubMed
    159. Herrero CJ, Alés E, Pintado AJ, López MG, García-Palomero E, Mahata SK, O'Connor DT, García AG, Montiel C. Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis. J Neurosci. 2002 Jan 15; 22(2):377-88. PMID: 11784782.
      View in: PubMed
    160. Jiang Q, Taupenot L, Mahata SK, Mahata M, O'Connor DT, Miles LA, Parmer RJ. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J Biol Chem. 2001 Jul 06; 276(27):25022-9. PMID: 11342539.
      View in: PubMed
    161. Taupenot L, Mahata SK, Mahata M, Parmer RJ, O'Connor DT. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism. Regul Pept. 2000 Nov 24; 95(1-3):9-17. PMID: 11062327.
      View in: PubMed
    162. Parmer RJ, Mahata M, Gong Y, Mahata SK, Jiang Q, O'Connor DT, Xi XP, Miles LA. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. J Clin Invest. 2000 Oct; 106(7):907-15. PMID: 11018079.
      View in: PubMed
    163. Mahapatra NR, Mahata M, Datta AK, Gerdes HH, Huttner WB, O'Connor DT, Mahata SK. Neuroendocrine cell type-specific and inducible expression of the chromogranin B gene: crucial role of the proximal promoter. Endocrinology. 2000 Oct; 141(10):3668-78. PMID: 11014221.
      View in: PubMed
    164. Mahata SK, Mahata M, Wakade AR, O'Connor DT. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity. Mol Endocrinol. 2000 Oct; 14(10):1525-35. PMID: 11043569.
      View in: PubMed
    165. Taylor CV, Taupenot L, Mahata SK, Mahata M, Wu H, Yasothornsrikul S, Toneff T, Caporale C, Jiang Q, Parmer RJ, Hook VY, O'Connor DT. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. J Biol Chem. 2000 Jul 28; 275(30):22905-15. PMID: 10781584.
      View in: PubMed
    166. Parmer RJ, Mahata SK, Jiang Q, Taupenot L, Gong Y, Mahata M, O'Connor DT, Miles LA. Tissue plasminogen activator and chromaffin cell function. Adv Exp Med Biol. 2000; 482:179-92. PMID: 11192579.
      View in: PubMed
    167. Mahata SK, Mahata M, Livsey Taylor CV, Taupenot L, Parmer RJ, O'Connor DT. The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function. Adv Exp Med Biol. 2000; 482:263-77. PMID: 11192587.
      View in: PubMed
    168. O'Connor DT, Mahata SK, Taupenot L, Mahata M, Livsey Taylor CV, Kailasam MT, Ziegler MG, Parmer RJ. Chromogranin A in human disease. Adv Exp Med Biol. 2000; 482:377-88. PMID: 11192598.
      View in: PubMed
    169. Taupenot L, Mahata M, Mahata SK, Wu H, O'Connor DT. Regulation of chromogranin A transcription and catecholamine secretion by the neuropeptide PACAP. Stimulation and desensitization. Adv Exp Med Biol. 2000; 482:97-111. PMID: 11192604.
      View in: PubMed
    170. Taupenot L, Mahata M, Mahata SK, O'Connor DT. Time-dependent effects of the neuropeptide PACAP on catecholamine secretion : stimulation and desensitization. Hypertension. 1999 Nov; 34(5):1152-62. PMID: 10567198.
      View in: PubMed
    171. Mahata SK, Mahata M, Livsey CV, Gerdes HH, Huttner WB, O'Connor DT. Neuroendocrine cell type-specific and inducible expression of the secretogranin II gene: crucial role of cyclic adenosine monophosphate and serum response elements. Endocrinology. 1999 Feb; 140(2):739-49. PMID: 9927301.
      View in: PubMed
    172. Mahata SK, Mahata M, Parmer RJ, O'Connor DT. Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance. J Biol Chem. 1999 Jan 29; 274(5):2920-8. PMID: 9915830.
      View in: PubMed
    173. O'Connor DT, Takiyyuddin MA, Printz MP, Dinh TQ, Barbosa JA, Rozansky DJ, Mahata SK, Wu H, Kennedy BP, Ziegler MG, Wright FA, Schlager G, Parmer RJ. Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press. 1999; 8(5-6):285-95. PMID: 10803489.
      View in: PubMed
    174. Mahata SK, Mahata M, Wu H, Parmer RJ, O'Connor DT. Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesis. Neuroscience. 1999 Jan; 88(2):405-24. PMID: 10197763.
      View in: PubMed
    175. Mahata M, Mahata SK, Parmer RJ, O'Connor DT. Proadrenomedullin N-terminal 20 peptide: minimal active region to regulate nicotinic receptors. Hypertension. 1998 Nov; 32(5):907-16. PMID: 9822452.
      View in: PubMed
    176. Tsigelny I, Mahata SK, Taupenot L, Preece NE, Mahata M, Khan I, Parmer RJ, O'Connor DT. Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity. Regul Pept. 1998 Oct 16; 77(1-3):43-53. PMID: 9809795.
      View in: PubMed
    177. Kong C, Gill BM, Rahimpour R, Xu L, Feldman RD, Xiao Q, McDonald TJ, Taupenot L, Mahata SK, Singh B, O'Connor DT, Kelvin DJ. Secretoneurin and chemoattractant receptor interactions. J Neuroimmunol. 1998 Aug 01; 88(1-2):91-8. PMID: 9688329.
      View in: PubMed
    178. Tang K, Wu H, Mahata SK, O'Connor DT. A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells. Mol Pharmacol. 1998 Jul; 54(1):59-69. PMID: 9658190.
      View in: PubMed
    179. Taupenot L, Mahata SK, Wu H, O'Connor DT. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP). J Clin Invest. 1998 Feb 15; 101(4):863-76. PMID: 9466982.
      View in: PubMed
    180. Mahata SK, Mahata M, Yoo SH, Taupenot L, Wu H, Aroda VR, Livsey CV, Taulane JP, Goodman M, Parmer RJ, O'Connor DT. A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis. Adv Pharmacol. 1998; 42:260-4. PMID: 9327894.
      View in: PubMed
    181. Kennedy BP, Mahata SK, O'Connor DT, Ziegler MG. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides. 1998; 19(7):1241-8. PMID: 9786174.
      View in: PubMed
    182. Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest. 1997 Sep 15; 100(6):1623-33. PMID: 9294131.
      View in: PubMed
    183. Tang K, Wu H, Mahata SK, Mahata M, Gill BM, Parmer RJ, O'Connor DT. Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C. J Clin Invest. 1997 Sep 01; 100(5):1180-92. PMID: 9276735.
      View in: PubMed
    184. Parmer RJ, Mahata M, Mahata S, Sebald MT, O'Connor DT, Miles LA. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem. 1997 Jan 17; 272(3):1976-82. PMID: 8999889.
      View in: PubMed
    185. Tang K, Wu H, Mahata SK, Taupenot L, Rozansky DJ, Parmer RJ, O'Connor DT. Stimulus-transcription coupling in pheochromocytoma cells. Promoter region-specific activation of chromogranin a biosynthesis. J Biol Chem. 1996 Nov 08; 271(45):28382-90. PMID: 8910462.
      View in: PubMed
    186. Mahata M, Mahata SK, Parmer RJ, O'Connor DT. Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion. Hypertension. 1996 Sep; 28(3):414-20. PMID: 8794826.
      View in: PubMed
    187. Mahata SK, Kozak CA, Szpirer J, Szpirer C, Modi WS, Gerdes HH, Huttner WB, O'Connor DT. Dispersion of chromogranin/secretogranin secretory protein family loci in mammalian genomes. Genomics. 1996 Apr 01; 33(1):135-9. PMID: 8617499.
      View in: PubMed
    188. Kroesen S, Marksteiner J, Mahata SK, Mahata M, Fischer-Colbrie R, Saria A, Kapeller I, Winkler H. Effects of haloperidol, clozapine and citalopram on messenger RNA levels of chromogranins A and B and secretogranin II in various regions of rat brain. Neuroscience. 1995 Dec; 69(3):881-91. PMID: 8596656.
      View in: PubMed
    189. Wu H, Mahata SK, Mahata M, Webster NJ, Parmer RJ, O'Connor DT. A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A. J Clin Invest. 1995 Jul; 96(1):568-78. PMID: 7615829.
      View in: PubMed
    190. O'Connor DT, Wu H, Gill BM, Rozansky DJ, Tang K, Mahata SK, Mahata M, Eskeland NL, Videen JS, Zhang X. Hormone storage vesicle proteins. Transcriptional basis of the widespread neuroendocrine expression of chromogranin A, and evidence of its diverse biological actions, intracellular and extracellular. Ann N Y Acad Sci. 1994 Sep 15; 733:36-45. PMID: 7978886.
      View in: PubMed
    191. Laslop A, Mahata SK, Wolkersdorfer M, Mahata M, Srivastava M, Seidah NG, Fischer-Colbrie R, Winkler H. Large dense-core vesicles in rat adrenal after reserpine: levels of mRNAs of soluble and membrane-bound constituents in chromaffin and ganglion cells indicate a biosynthesis of vesicles with higher secretory quanta. J Neurochem. 1994 Jun; 62(6):2448-56. PMID: 8189248.
      View in: PubMed
    192. Kirchmair R, Marksteiner J, Troger J, Mahata SK, Mahata M, Donnerer J, Amann R, Fischer-Colbrie R, Winkler H, Saria A. Human and rat primary C-fibre afferents store and release secretoneurin, a novel neuropeptide. Eur J Neurosci. 1994 May 01; 6(5):861-8. PMID: 8075827.
      View in: PubMed
    193. Marksteiner J, Mahata SK, Pycha R, Mahata M, Saria A, Fischer-Colbrie R, Winkler H. Distribution of secretoneurin immunoreactivity in the spinal cord and lower brainstem in comparison with that of substance P and calcitonin gene-related peptide. J Comp Neurol. 1994 Feb 08; 340(2):243-54. PMID: 7515398.
      View in: PubMed
    194. Mahata M, Mahata SK, Fischer-Colbrie R, Winkler H. Ontogenic development and distribution of mRNAs of chromogranin A and B, secretogranin II, p65 and synaptin/synaptophysin in rat brain. Brain Res Dev Brain Res. 1993 Nov 19; 76(1):43-58. PMID: 8306430.
      View in: PubMed
    195. Mahata M, Hörtnagl H, Mahata SK, Fischer-Colbrie R, Winkler H. Messenger RNA levels of chromogranin B, secretogranin II, and VGF in rat brain after AF64A-induced septohippocampal cholinergic lesions. J Neurochem. 1993 Nov; 61(5):1648-56. PMID: 8228984.
      View in: PubMed
    196. Mahata SK, Mahata M, Fischer-Colbrie R, Winkler H. Reserpine causes differential changes in the mRNA levels of chromogranin B, secretogranin II, carboxypeptidase H, alpha-amidating monooxygenase, the vesicular amine transporter and of synaptin/synaptophysin in rat brain. Brain Res Mol Brain Res. 1993 Jul; 19(1-2):83-92. PMID: 8361347.
      View in: PubMed
    197. Mahata SK, Mahata M, Fischer-Colbrie R, Winkler H. Vesicle monoamine transporters 1 and 2: differential distribution and regulation of their mRNAs in chromaffin and ganglion cells of rat adrenal medulla. Neurosci Lett. 1993 Jun 25; 156(1-2):70-2. PMID: 8414192.
      View in: PubMed
    198. Mahata SK, Mahata M, Hörtnag H, Fischer-Colbrie R, Steiner HJ, Dietze O, Winkler H. Concomitant changes of messenger ribonucleic acid levels of secretogranin II, VGF, vasopressin and oxytocin in the paraventricular nucleus of rats after adrenalectomy and during lactation. J Neuroendocrinol. 1993 Jun; 5(3):323-30. PMID: 8319005.
      View in: PubMed
    199. Marksteiner J, Kirchmair R, Mahata SK, Mahata M, Fischer-Colbrie R, Hogue-Angeletti R, Saria A, Winkler H. Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain: an immunocytochemical and radioimmunological study. Neuroscience. 1993 Jun; 54(4):923-44. PMID: 8341425.
      View in: PubMed
    200. Mahata SK, Mahata M, Fischer-Colbrie R, Winkler H. In situ hybridization: mRNA levels of secretogranin II, VGF and peptidylglycine alpha-amidating monooxygenase in brain of salt-loaded rats. Histochemistry. 1993 Apr; 99(4):287-93. PMID: 8500992.
      View in: PubMed
    201. Mahata SK, Gruber B, Mahata M, Röder C, Fischer-Colbrie R, Sperk G. Kainic acid seizures in the rat: differential expression of chromogranin A, carboxypeptidase H and peptidylglycine alpha-amidating monooxigenase in subfields of the hippocampal formation. Acta Neuropathol. 1993; 86(6):590-5. PMID: 8310814.
      View in: PubMed
    202. Mahata SK, Marksteiner J, Sperk G, Mahata M, Gruber B, Fischer-Colbrie R, Winkler H. Temporal lobe epilepsy of the rat: differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfield of the hippocampus. Brain Res Mol Brain Res. 1992 Nov; 16(1-2):1-12. PMID: 1334187.
      View in: PubMed
    203. Fischer-Colbrie R, Schmid KW, Mahata SK, Mahata M, Laslop A, Bauer JW. Sex-Related Differences in Chromogranin A, Chromogranin B and Secretogranin II Gene Expression in Rat Pituitary. J Neuroendocrinol. 1992 Feb; 4(1):125-30. PMID: 21554587.
      View in: PubMed
    204. Mahata SK, Mahata M, Steiner HJ, Fischer-Colbrie R, Winkler H. In situ hybridization: mRNA levels of secretogranin II, neuropeptides and carboxypeptidase H in brains of salt-loaded and Brattleboro rats. Neuroscience. 1992; 48(3):669-80. PMID: 1376456.
      View in: PubMed
    205. Mahata M, Mahata SK. Effect of steroid hormones on serotonin, norepinephrine and epinephrine contents in the pineal-paraphyseal complex of the soft-shelled turtle (Lissemys punctata punctata). J Comp Physiol B. 1992; 162(6):520-5. PMID: 1430421.
      View in: PubMed
    206. Mahapatra MS, Mahata SK, Maiti B. Effect of stress on serotonin, norepinephrine, epinephrine and corticosterone contents in the soft-shelled turtle. Clin Exp Pharmacol Physiol. 1991 Oct; 18(10):719-24. PMID: 1722440.
      View in: PubMed
    207. Mahata SK, Ghosh A. Neural influence on oxytocin-induced changes of adrenomedullary catecholamines in the pigeon. Regul Pept. 1991 Apr 25; 33(2):183-90. PMID: 1882084.
      View in: PubMed
    208. Mahata SK. Effect of insulin on serotonin, 5-hydroxyindole-acetic acid, norepinephrine, epinephrine and corticosterone contents in chick. Neurosci Lett. 1991 Jan 02; 121(1-2):115-8. PMID: 1708470.
      View in: PubMed
    209. Mahata SK, Ghosh A. Role of splanchnic nerve on steroid-hormone-induced alteration of adrenomedullary catecholamines in untreated and reserpinized pigeon. J Comp Physiol B. 1991; 161(6):598-601. PMID: 1783691.
      View in: PubMed
    210. Mahata SK, Ghosh A. Neural modulation of lysine vasopressin-induced changes of catecholamines in the adrenal medulla of the pigeon. Neuropeptides. 1991 Jan; 18(1):29-33. PMID: 2046887.
      View in: PubMed
    211. Mahata SK, Mahata M, Marksteiner J, Sperk G, Fischer-Colbrie R, Winkler H. Distribution of mRNAs for Chromogranins A and B and Secretogranin II in Rat Brain. Eur J Neurosci. 1991; 3(9):895-904. PMID: 12106456.
      View in: PubMed
    212. Mahata SK, De M, Pal D, Ghosh A. Effect of stress on the catecholamine content of the adrenal gland of intact and bursectomized chicks. Clin Exp Pharmacol Physiol. 1990 Nov; 17(11):805-8. PMID: 2078908.
      View in: PubMed
    213. Mahata SK, Ghosh A. Neural influence on the action of insulin in the adrenomedullary catecholamine content in the pigeon. Neurosci Lett. 1990 Aug 24; 116(3):336-40. PMID: 2243613.
      View in: PubMed
    214. Mahapatra MS, Mahata SK, Maiti BR. Effect of ambient temperature on serotonin, norepinephrine, and epinephrine contents in the pineal-paraphyseal complex of the soft-shelled turtle (Lissemys punctata punctata). Gen Comp Endocrinol. 1989 May; 74(2):215-20. PMID: 2714626.
      View in: PubMed
    215. Mahata SK, Ghosh A. Influence of splanchnic nerve on reserpine action in avian adrenal medulla. Gen Comp Endocrinol. 1989 Feb; 73(2):165-72. PMID: 2707578.
      View in: PubMed
    216. Mahapatra MS, Mahata SK, Maiti BR. Circadian rhythms and influence of light on serotonin, norepinephrine, and epinephrine contents in the pineal-paraphyseal complex of soft-shelled turtles (Lissemys punctata punctata). Gen Comp Endocrinol. 1988 Jul; 71(1):183-8. PMID: 3410296.
      View in: PubMed
    217. Mahata SK, Mandal A, Ghosh A. Influence of age and splanchnic nerve on the action of melatonin in the adrenomedullary catecholamine content and blood glucose level in the avian group. J Comp Physiol B. 1988; 158(5):601-7. PMID: 3249022.
      View in: PubMed
    218. Mahapatra MS, Mahata SK, Maiti BR. Effects of reserpine and chlorpromazine on the serotonin, norepinephrine, and epinephrine levels in the pineal-paraphyseal complex of soft-shelled turtles (Lissemys punctata punctata). Gen Comp Endocrinol. 1987 Oct; 68(1):124-8. PMID: 3666419.
      View in: PubMed
    219. Mahapatra MS, Mahata SK, Maiti BR. Influence of age on diurnal rhythms of adrenal norepinephrine, epinephrine, and corticosterone levels in soft-shelled turtles (Lissemys punctata punctata). Gen Comp Endocrinol. 1987 Sep; 67(3):279-81. PMID: 3666405.
      View in: PubMed
    220. Mahapatra MS, Mahata SK, Maiti BR. Circadian rhythms in serotonin, norepinephrine, and epinephrine contents of the pineal-paraphyseal complex of the soft-shelled turtle (Lissemys punctata punctata). Gen Comp Endocrinol. 1986 Nov; 64(2):246-9. PMID: 3557091.
      View in: PubMed
    221. Mahata SK, Ghosh A. Effect of denervation and/or reserpine-induced changes on adrenomedullary catecholamines in pigeon: a fluorescence histochemical study. Basic Appl Histochem. 1985; 29(4):331-6. PMID: 4096685.
      View in: PubMed